← Back to Search

Low nicotine content vape with tobacco e-liquids for Tobacco Use

N/A
Waitlist Available
Led By Eric M Donny, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial will test if banning regular nicotine cigarettes encourages smokers to switch to less harmful products, or if higher nicotine/flavored alternatives are needed.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of cigarettes purchased
Secondary outcome measures
Amount of E-liquid purchased
Minnesota Nicotine Withdrawal Scale Scores
Perceived Health Risk Scale Scores
+5 more
Other outcome measures
Biomarkers of exposure during Field Assessment - Carbon Monoxide
Biomarkers of exposure during Field Assessment - Cotinine
Product use themes emerging from the qualitative interviews
+1 more

Trial Design

4Treatment groups
Experimental Treatment
Group I: Normal nicotine content vape with tobacco e-liquidsExperimental Treatment1 Intervention
Normal nicotine content vape with tobacco e-liquids
Group II: Normal Nicotine Content Vape with all flavor e-liquidsExperimental Treatment1 Intervention
Normal Nicotine Content Vape with all flavor e-liquids
Group III: Low nicotine content vape with tobacco e-liquidsExperimental Treatment1 Intervention
Low nicotine content vape with tobacco e-liquids
Group IV: Low nicotine content vape with all flavor e-liquidsExperimental Treatment1 Intervention
Low nicotine content vape with all flavor e-liquids

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,250 Previous Clinical Trials
1,007,114 Total Patients Enrolled
3 Trials studying Tobacco Use
40,715 Patients Enrolled for Tobacco Use
National Institute on Drug Abuse (NIDA)NIH
2,485 Previous Clinical Trials
2,622,316 Total Patients Enrolled
30 Trials studying Tobacco Use
6,170 Patients Enrolled for Tobacco Use
National Institutes of Health (NIH)NIH
2,720 Previous Clinical Trials
7,494,163 Total Patients Enrolled
8 Trials studying Tobacco Use
8,402 Patients Enrolled for Tobacco Use
~23 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top